molecular medicine spa
(MLM:Borsa Italia MTA (Equities))
Earnings & Estimates Summary - MOLECULAR MEDICINE SPA (MLM)
2013 revenues at MolMed S.p.A. totaled €6.7M EUR, while annual losses equaled €0.08 per share.
Quarterly Earnings & Estimates - MOLECULAR MEDICINE SPA (MLM)
MolMed S.p.A.'s Quarterly Earnings
MolMed S.p.A. reported 2nd quarter 2014 losses of €0.02 per share on 08/4/2014.
Annual Earnings & Estimates - MOLECULAR MEDICINE SPA (MLM)
MolMed S.p.A.'s Annual Earnings
MolMed S.p.A. reported annual 2013 losses of €0.08 per share on 03/5/2014.
Quarterly Revenues - MOLECULAR MEDICINE SPA (MLM)
MolMed S.p.A.'s Quarterly Revenues
MolMed S.p.A. had 2nd quarter 2014 revenues of €3.3M EUR. This bettered the €1.8M EUR estimate of the one analyst covering the company. This was 132.4% above the prior year's 2nd quarter results.
Annual Revenues - MOLECULAR MEDICINE SPA (MLM)
MolMed S.p.A.'s Annual Revenues
MolMed S.p.A. had revenues for the full year 2013 of €6.7M EUR. This was 32.7% above the prior year's results.
|No competitor information is available for MLM.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|